{"schema_version":"secwatch.filing_event.v1","accession":"0000896622-24-000006","form_type":"8-K","ticker":"ATR","cik":"0000896622","company_name":"APTARGROUP, INC.","filed_at":"2024-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.218480+00:00","generated_at":"2026-06-06T06:14:40.760146+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Aptar Q4 adjusted EPS $1.21 (up 27%), FY 2023 revenue $3.49B, guides Q1 2024 EPS $1.10-$1.18","bullets":["Q4 reported sales $838M (+5%), net income $62M (+6%), adjusted EPS $1.21 vs $0.95 (up 27%).","FY 2023 sales $3.49B (+5%), net income $284M (+19%), adjusted EPS $4.78 vs $3.87 (up 24%).","Pharma core sales +11% in Q4 driven by proprietary drug delivery systems; Beauty -6%, Closures -4%.","Q1 2024 adjusted EPS guidance $1.10-$1.18; expects continued Pharma growth and market recovery.","Dividend $0.41 payable Feb 22; repurchased 81k shares for $10.3M in Q4."],"urls":{"canonical":"https://secwatch.observer/filing/0000896622-24-000006","json":"https://secwatch.observer/filing/0000896622-24-000006.json","markdown":"https://secwatch.observer/filing/0000896622-24-000006.md","text":"https://secwatch.observer/filing/0000896622-24-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/896622/000089662224000006/0000896622-24-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/896622/000089662224000006/atr-20240208.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T06:14:40.760146+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"70a66ff0ca4b8503299afbea97849c677793336e","claim":"APTARGROUP, INC. reported the quarter ended December 31, 2023 results: net income $62 million, EPS $0.93.","evidence_excerpt":"Fourth Quarter 2023 Highlights • Reported sales increased 5% and net income increased 6% to $62 million • Core sales increased 2% and adjusted EBITDA increased 22% from the prior year to $179 million • Reported earnings per share increased about 4% to $0.93 compared to $0.89 in the prior year","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/896622/000089662224000006/0000896622-24-000006-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended December 31, 2023"},{"label":"Net income","value":"$62 million"},{"label":"EPS","value":"$0.93"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"f92df30f00f3827e415bbf91b882dac1f2f11f27","claim":"APTARGROUP, INC. reported the year ended December 31, 2023 results: revenue $3.5 billion, net income $284 million, EPS $4.25.","evidence_excerpt":"Annual 2023 Highlights • Achieved annual sales of $3.5 billion, with sales growth driven evenly by favorable product mix, volume growth and pricing • Reported sales grew 5% and core sales increased 3% • Reported earnings per share increased 18% to $4.25 and adjusted earnings per share increased 24% to $4.78 • Reported net income increased 19% to $284 million and adjusted EBITDA increased 15% to $708 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/896622/000089662224000006/0000896622-24-000006-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2023"},{"label":"Revenue","value":"$3.5 billion"},{"label":"Net income","value":"$284 million"},{"label":"EPS","value":"$4.25"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}